\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ gen\\:\\ fatigued\\ appearing\\ thin\\ male\\ with\\ diffuse\\ psychomotor\\ slowing\\;\\ diffuse\\ petechial\\ rash\\ involving\\ abdomen\\,\\ chest\\ and\\ back\\,\\ no\\ organomegaly\\ or\\ masses\\ detected\\,\\ no\\ bruits\\;\\ small\\ papular\\ lesions\\ involving\\ dorsum\\ of\\ hands\\,\\ elbows\\ and\\ feet\\,\\ splinter\\ hemorrhages\\,\\ rash\\ per\\ above\\ neuro\\:\\ left\\ l5\\ peroneal\\ nerve\\ cutaneous\\ anesthesia\\,\\ bilateral\\ s1\\ clonus\\ r\\>l\ \(0\)\
\-\ laboratory\\:\\ cbc\\:\\ wbc\\:\\ 19k\\,\\ 40\\%\\ eos\\,\\ 94\\%\\ neu\\;\\ hct\\:35\\,\\ plt\\:200k\\,\\ ua\\:\\ 1013\\/7\\.0\\,\\ 2\\+\\ blood\\,\\ 3\\+\\ protein\\;\\ 24\\ hr\\ protein\\ 1194\\ mg\\ cxr\\:\\ cardiac\\ silhouette\\ mildly\\ enlarged\\,\\ otherwise\\ normal\\;\\ esr\\:\\ 73\\,\\ c\\-reactive\\ protein\\:\\ 13\\ \\(n10\\-0\\.6\\)\\,\\ rheumatoid\\ factor\\:\\ 115\\ \\(nl\\<10\\)\\ ige\\:\\ 600\\ wml\\ \\(nl\\ 10\\-150\\)\\ streptozyme\\:\\ positive\\ 1\\:400\\ \\(nl\\ \\<1\\:100\\)\\;\\ echo\\:\\ normal\\ lv\\ function\\,\\ normal\\ valves\\,\\ small\\ pericardial\\ effusion\\;\\ hepatitis\\ panel\\:\\ negative\\;\\ c3\\:\\ 188\\ \\(nl\\ 88\\-201\\)\\;\\ c4\\:\\ 37\\ \\(nl\\ 20\\-59\\)\\;\\ c\\-anca\\:\\ negative\\;\\ p\\-anca\\:\\ negative\\,\\ ana\\:\\ negative\\,\\ cryo\\:\\ negative\\;\\ blood\\ cultures\\,\\ urine\\ cultures\\,\\ stool\\ cultures\\(o\\+p\\)\\-\\ \\-\\ all\\ negative\\;\\ ssa\\/ssb\\:\\ negative\\;\\ rpr\\:\\ nr\\;\\ hiv\\:\\ negative\\;\\ gc\\ cx\\:\\ negative\\;\\ richettsial\\ 96\\:\\ negative\\;\\ brucella\\ antibody\\:\\ \\<1\\:80\\ \ \(0\)\
\-\ histopathology\\:two\\ diagnostic\\ procedures\\ were\\ performed\\.\\ renal\\ bx\\:\\ cfw\\ churg\\ strauss\\.\\ skin\\ bx\\:\\ c\\/w\\ churg\\ strauss\\.\\ bacterial\\ and\\ fungal\\ cultures\\ \\-\\ negative\ \(0\)\
\-\ initiate\\ treatment\\ started\\ with\\ cyclophosphamide\\.\ \(0\)\
\-\ churg\\-strauss\\ syndrome\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#16\\)\\ captain\\ d\\.\\ schissel\\,\\ mc\\,\\ usa\ \(0\)\
\-\ patient\\ evaluated\\ for\\ renal\\ insufficiency\\ \\(bun\\/creat\\ \\:\\ 23\\/1\\.7\\)\\,\\ proteinuria\\ \\(1140mg\\/24hrs\\)\\,\\ and\\ microscopic\\ hematuria\\.\\ he\\ was\\ apparently\\ well\\ until\\ 8\\ weeks\\ earlier\\ when\\ he\\ developed\\ a\\ papulovesicular\\ facial\\ rash\\ while\\ on\\ active\\ duty\\ in\\ the\\ persian\\ gulf\\.\\ he\\ was\\ treated\\ for\\ \\"acne\\"\\ with\\ tetracycline\\ for\\ 10\\ days\\ with\\ minimal\\ improvement\\.\\ he\\ then\\ took\\ ibuprofen\\ for\\ several\\ days\\ for\\ muscular\\ back\\ pain\\.\\ he\\ sought\\ medical\\ attention\\ shortly\\ after\\ he\\ returned\\ to\\ the\\ u\\.s\\.\\ due\\ to\\ progressive\\ fatigue\\,\\ rash\\,\\ low\\ grade\\ fevers\\,\\ weight\\ loss\\,\\ \\"clumsiness\\"\\ and\\ inability\\ to\\ concentrate\\.\\ other\\ than\\ albuterol\\ and\\ triamcinolone\\ inhalers\\ that\\ he\\ used\\ for\\ chronic\\ well\\-controlled\\ asthma\\,\\ he\\ took\\ no\\ other\\ medications\\,\\ and\\ was\\ previously\\ healthy\\.\\ there\\ was\\ no\\ prior\\ history\\ or\\ family\\ history\\ of\\ renal\\ disease\\ or\\ urinary\\ abnormalities\\.\\ there\\ was\\ no\\ gross\\ hematuria\\,\\ arthritis\\,\\ oral\\ ulcerations\\,\\ sinusitis\\,\\ ha\\,\\ hemoptysis\\,\\ cough\\,\\ chest\\ or\\ abdominal\\ pain\\ or\\ sob\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\;\\:\\ 0\\.07773471512184794\ \(0\)\
\-\ \\:\\:\\ 0\\.07470899636612072\ \(0\)\
\-\ negative\\:\\ 0\\.05985782894482648\ \(0\)\
\-\ nl\\:\\ 0\\.057033928797087116\ \(0\)\
\-\ rash\\:\\ 0\\.04438891694091491\ \(0\)\
\-\ he\\:\\ 0\\.04066844080226899\ \(0\)\
\-\ churg\\:\\ 0\\.037592829100070356\ \(0\)\
\-\ strauss\\:\\ 0\\.037592829100070356\ \(0\)\
\-\ cultures\\:\\ 0\\.03749831826157697\ \(0\)\
\-\ bx\\:\\ 0\\.028223001478167496\ \(0\)\
\-\ protein\\:\\ 0\\.028047131930425483\ \(0\)\
\-\ took\\:\\ 0\\.023866279740291246\ \(0\)\
\-\ \\,\\:\\ 0\\.02308827850893709\ \(0\)\
\-\ \\<\\:\\ 0\\.02109636797975559\ \(0\)\
\-\ psychomotor\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ petechial\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ splinter\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ hct\\:35\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ plt\\:200k\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 1013\\/7\\.0\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 1194\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ n10\\-0\\.6\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ wml\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 10\\-150\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ streptozyme\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 1\\:400\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 88\\-201\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 20\\-59\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ cryo\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ o\\+p\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ ssa\\/ssb\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ richettsial\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ brucella\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ cfw\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ captain\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ schissel\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 23\\/1\\.7\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ 1140mg\\/24hrs\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ papulovesicular\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ persian\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ fatigued\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ papular\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 19k\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ neu\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 1\\:100\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ c\\-anca\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ p\\-anca\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ gc\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 1\\:80\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ bun\\/creat\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ gulf\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ hematuria\\:\\ 0\\.017285051126519155\ \(0\)\
\-\ 188\\:\\ 0\\.016453957644559463\ \(0\)\
\-\ churg\\-strauss\\:\\ 0\\.016453957644559463\ \(0\)\
\-\ triamcinolone\\:\\ 0\\.016453957644559463\ \(0\)\
\-\ inhalers\\:\\ 0\\.016453957644559463\ \(0\)\
\-\ renal\\:\\ 0\\.016423084538111317\ \(0\)\
\-\ tetracycline\\:\\ 0\\.015840563033788075\ \(0\)\
\-\ well\\-controlled\\:\\ 0\\.015840563033788075\ \(0\)\
\-\ \\(\\:\\ 0\\.015402169003067389\ \(0\)\
\-\ ige\\:\\ 0\\.0153647772100904\ \(0\)\
\-\ nr\\:\\ 0\\.0153647772100904\ \(0\)\
\-\ initiate\\:\\ 0\\.0153647772100904\ \(0\)\
\-\ concentrate\\:\\ 0\\.0153647772100904\ \(0\)\
\-\ \\)\\:\\ 0\\.015214023285997975\ \(0\)\
\-\ clumsiness\\:\\ 0\\.014976031886435912\ \(0\)\
\-\ 600\\:\\ 0\\.014647352398531311\ \(0\)\
\-\ acne\\:\\ 0\\.014647352398531311\ \(0\)\
\-\ eos\\:\\ 0\\.014362637275664525\ \(0\)\
\-\ elbows\\:\\ 0\\.014111500739083748\ \(0\)\
\-\ 115\\:\\ 0\\.014111500739083748\ \(0\)\
\-\ cx\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ u\\.s\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ ulcerations\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ 3\\+\\:\\ 0\\.013498106128312362\ \(0\)\
\-\ c\\-reactive\\:\\ 0\\.013498106128312362\ \(0\)\
\-\ rpr\\:\\ 0\\.013498106128312362\ \(0\)\
\-\ proteinuria\\:\\ 0\\.013498106128312362\ \(0\)\
\-\ albuterol\\:\\ 0\\.013498106128312362\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.01316942664040776\ \(0\)\
\-\ sought\\:\\ 0\\.01316942664040776\ \(0\)\
\-\ slowing\\:\\ 0\\.013022320304614686\ \(0\)\
\-\ clonus\\:\\ 0\\.013022320304614686\ \(0\)\
\-\ 94\\:\\ 0\\.013022320304614686\ \(0\)\
\-\ hemorrhages\\:\\ 0\\.012884711517540974\ \(0\)\
\-\ lv\\:\\ 0\\.012884711517540974\ \(0\)\
\-\ involving\\:\\ 0\\.012786384921122787\ \(0\)\
\-\ peroneal\\:\\ 0\\.0126335749809602\ \(0\)\
\-\ 96\\:\\ 0\\.0126335749809602\ \(0\)\
\-\ c\\/w\\:\\ 0\\.0126335749809602\ \(0\)\
\-\ usa\\:\\ 0\\.0126335749809602\ \(0\)\
\-\ bruits\\:\\ 0\\.012408925693843298\ \(0\)\
\-\ ana\\:\\ 0\\.012408925693843298\ \(0\)\
\-\ 10\\:\\ 0\\.012284111847961238\ \(0\)\
\-\ dorsum\\:\\ 0\\.012205705694260516\ \(0\)\
\-\ anesthesia\\:\\ 0\\.012110925816710765\ \(0\)\
\-\ antibody\\:\\ 0\\.012110925816710765\ \(0\)\
\-\ ha\\:\\ 0\\.012110925816710765\ \(0\)\
\-\ back\\:\\ 0\\.012021604841567066\ \(0\)\
\-\ apparently\\:\\ 0\\.011933139870145623\ \(0\)\
\-\ c4\\:\\ 0\\.011769043833608037\ \(0\)\
\-\ ibuprofen\\:\\ 0\\.011769043833608037\ \(0\)\
\-\ \\-\\:\\ 0\\.011716813168710214\ \(0\)\
\-\ organomegaly\\:\\ 0\\.011616679304861457\ \(0\)\
\-\ microscopic\\:\\ 0\\.011616679304861457\ \(0\)\
\-\ c3\\:\\ 0\\.011544394546491135\ \(0\)\
\-\ valves\\:\\ 0\\.011406785759417422\ \(0\)\
\-\ 73\\:\\ 0\\.011215715058586534\ \(0\)\
\-\ attention\\:\\ 0\\.011215715058586534\ \(0\)\
\-\ days\\:\\ 0\\.011168760324827196\ \(0\)\
\-\ diffuse\\:\\ 0\\.011032014585822238\ \(0\)\
\-\ d\\.\\:\\ 0\\.010826969734932046\ \(0\)\
\-\ muscular\\:\\ 0\\.010826969734932046\ \(0\)\
\-\ panel\\:\\ 0\\.010727779936136965\ \(0\)\
\-\ mc\\:\\ 0\\.010679863399138973\ \(0\)\
\-\ or\\:\\ 0\\.010677214807715432\ \(0\)\
\-\ sob\\:\\ 0\\.010633000058587213\ \(0\)\
\-\ cutaneous\\:\\ 0\\.010587144610354883\ \(0\)\
\-\ sinusitis\\:\\ 0\\.01054225461206526\ \(0\)\
\-\ was\\:\\ 0\\.010536007699506255\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.010498290247027444\ \(0\)\
\-\ hepatitis\\:\\ 0\\.010455214112022071\ \(0\)\
\-\ inability\\:\\ 0\\.010455214112022071\ \(0\)\
\-\ shortly\\:\\ 0\\.010371587857963903\ \(0\)\
\-\ silhouette\\:\\ 0\\.010330973369753468\ \(0\)\
\-\ l5\\:\\ 0\\.010213575124160658\ \(0\)\
\-\ 1997\\:\\ 0\\.010213575124160658\ \(0\)\
\-\ histopathology\\:\\ 0\\.010175836153799463\ \(0\)\
\-\ seminar\\:\\ 0\\.010138753546737909\ \(0\)\
\-\ hiv\\:\\ 0\\.010102304861536841\ \(0\)\
\-\ asthma\\:\\ 0\\.010066468788367587\ \(0\)\
\-\ gen\\:\\ 0\\.0100312250741859\ \(0\)\
\-\ stool\\:\\ 0\\.0100312250741859\ \(0\)\
\-\ uniformed\\:\\ 0\\.0100312250741859\ \(0\)\
\-\ mg\\:\\ 0\\.009996554453990206\ \(0\)\
\-\ blood\\:\\ 0\\.009946315874240082\ \(0\)\
\-\ procedures\\:\\ 0\\.009863248788784803\ \(0\)\
\-\ services\\:\\ 0\\.009831185084382799\ \(0\)\
\-\ dermatology\\:\\ 0\\.009831185084382799\ \(0\)\
\-\ pericardial\\:\\ 0\\.009799596415331324\ \(0\)\
\-\ fatigue\\:\\ 0\\.009737789300462983\ \(0\)\
\-\ ua\\:\\ 0\\.009677723464713097\ \(0\)\
\-\ insufficiency\\:\\ 0\\.009677723464713097\ \(0\)\
\-\ detected\\:\\ 0\\.009619303477105177\ \(0\)\
\-\ duty\\:\\ 0\\.009507056710611741\ \(0\)\
\-\ echo\\:\\ 0\\.009479894608740888\ \(0\)\
\-\ hands\\:\\ 0\\.009426586928132322\ \(0\)\
\-\ neuro\\:\\ 0\\.009400424683800096\ \(0\)\
\-\ s1\\:\\ 0\\.009400424683800096\ \(0\)\
\-\ for\\:\\ 0\\.009327609577518743\ \(0\)\
\-\ feet\\:\\ 0\\.00932381059163365\ \(0\)\
\-\ 2\\+\\:\\ 0\\.00932381059163365\ \(0\)\
\-\ bacterial\\:\\ 0\\.00932381059163365\ \(0\)\
\-\ returned\\:\\ 0\\.00932381059163365\ \(0\)\
\-\ factor\\:\\ 0\\.009298872340539424\ \(0\)\
\-\ esr\\:\\ 0\\.009225761309668143\ \(0\)\
\-\ no\\:\\ 0\\.00917317857893179\ \(0\)\
\-\ 37\\:\\ 0\\.009155074300463662\ \(0\)\
\-\ earlier\\:\\ 0\\.008998717641432641\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.008955799734037598\ \(0\)\
\-\ hr\\:\\ 0\\.008873258153110821\ \(0\)\
\-\ fungal\\:\\ 0\\.008833026843293372\ \(0\)\
\-\ urine\\:\\ 0\\.008793540600719307\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.008783579965809139\ \(0\)\
\-\ chest\\:\\ 0\\.008719526652697308\ \(0\)\
\-\ gross\\:\\ 0\\.008679288476765988\ \(0\)\
\-\ fevers\\:\\ 0\\.008660827788614357\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.00860638578007456\ \(0\)\
\-\ normal\\:\\ 0\\.008568949602979324\ \(0\)\
\-\ improvement\\:\\ 0\\.008501502530200846\ \(0\)\
\-\ \\%\\:\\ 0\\.00850030291405547\ \(0\)\
\-\ urinary\\:\\ 0\\.008434341193187263\ \(0\)\
\-\ other\\:\\ 0\\.008399311508326006\ \(0\)\
\-\ small\\:\\ 0\\.008394777332115645\ \(0\)\
\-\ evaluated\\:\\ 0\\.008353259326259247\ \(0\)\
\-\ l\\:\\ 0\\.008306050102640454\ \(0\)\
\-\ r\\:\\ 0\\.008275148168093403\ \(0\)\
\-\ 16\\:\\ 0\\.008244687704879168\ \(0\)\
\-\ 13\\:\\ 0\\.008229619118049546\ \(0\)\
\-\ healthy\\:\\ 0\\.008214656276559896\ \(0\)\
\-\ cbc\\:\\ 0\\.008141377718981628\ \(0\)\
\-\ started\\:\\ 0\\.008127019441409465\ \(0\)\
\-\ medications\\:\\ 0\\.008127019441409465\ \(0\)\
\-\ appearing\\:\\ 0\\.008098589738063057\ \(0\)\
\-\ until\\:\\ 0\\.008001968850617337\ \(0\)\
\-\ per\\:\\ 0\\.007975148419472647\ \(0\)\
\-\ facial\\:\\ 0\\.007922498925676544\ \(0\)\
\-\ arthritis\\:\\ 0\\.007784077718641758\ \(0\)\
\-\ mildly\\:\\ 0\\.007759847956061128\ \(0\)\
\-\ function\\:\\ 0\\.007724011882891872\ \(0\)\
\-\ cxr\\:\\ 0\\.007688768168710186\ \(0\)\
\-\ oral\\:\\ 0\\.007677148542340112\ \(0\)\
\-\ 40\\:\\ 0\\.007665591895283951\ \(0\)\
\-\ previously\\:\\ 0\\.007654097548514493\ \(0\)\
\-\ thin\\:\\ 0\\.0074887281789070845\ \(0\)\
\-\ family\\:\\ 0\\.007467617153357592\ \(0\)\
\-\ diagnostic\\:\\ 0\\.00721998463755236\ \(0\)\
\-\ progressive\\:\\ 0\\.007201362718642437\ \(0\)\
\-\ minimal\\:\\ 0\\.007173731280172276\ \(0\)\
\-\ \\#\\:\\ 0\\.00714645334528974\ \(0\)\
\-\ 24\\:\\ 0\\.0070841300226566085\ \(0\)\
\-\ developed\\:\\ 0\\.007015064999647579\ \(0\)\
\-\ skin\\:\\ 0\\.006998142719059654\ \(0\)\
\-\ used\\:\\ 0\\.006989731677927423\ \(0\)\
\-\ cough\\:\\ 0\\.006981353686157936\ \(0\)\
\-\ active\\:\\ 0\\.006956415435063711\ \(0\)\
\-\ cardiac\\:\\ 0\\.006939950518019126\ \(0\)\
\-\ grade\\:\\ 0\\.006939950518019126\ \(0\)\
\-\ effusion\\:\\ 0\\.00692361177016077\ \(0\)\
\-\ 8\\:\\ 0\\.0068126173949879494\ \(0\)\
\-\ laboratory\\:\\ 0\\.006714481313121676\ \(0\)\
\-\ abnormalities\\:\\ 0\\.006692461879953553\ \(0\)\
\-\ above\\:\\ 0\\.00667790758342818\ \(0\)\
\-\ wbc\\:\\ 0\\.006641950640886593\ \(0\)\
\-\ nerve\\:\\ 0\\.0065649171140454285\ \(0\)\
\-\ otherwise\\:\\ 0\\.006544382160823763\ \(0\)\
\-\ weight\\:\\ 0\\.006530801247635107\ \(0\)\
\-\ then\\:\\ 0\\.006483937907083347\ \(0\)\
\-\ enlarged\\:\\ 0\\.0062166760562558775\ \(0\)\
\-\ masses\\:\\ 0\\.006159045624725133\ \(0\)\
\-\ \\>\\:\\ 0\\.006053662078184572\ \(0\)\
\-\ positive\\:\\ 0\\.005912336013398969\ \(0\)\
\-\ several\\:\\ 0\\.005857340801113832\ \(0\)\
\-\ while\\:\\ 0\\.00573272759030344\ \(0\)\
\-\ medical\\:\\ 0\\.005606204264533058\ \(0\)\
\-\ treated\\:\\ 0\\.00545383973578648\ \(0\)\
\-\ there\\:\\ 0\\.005423094057419994\ \(0\)\
\-\ abdomen\\:\\ 0\\.005397407810012146\ \(0\)\
\-\ loss\\:\\ 0\\.005288836188632067\ \(0\)\
\-\ two\\:\\ 0\\.005218190272102357\ \(0\)\
\-\ when\\:\\ 0\\.005218190272102357\ \(0\)\
\-\ syndrome\\:\\ 0\\.0052108882233148\ \(0\)\
\-\ weeks\\:\\ 0\\.005171167925162363\ \(0\)\
\-\ all\\:\\ 0\\.00515335498812642\ \(0\)\
\-\ chronic\\:\\ 0\\.005132174057371002\ \(0\)\
\-\ performed\\:\\ 0\\.005080124373619017\ \(0\)\
\-\ low\\:\\ 0\\.005066456402700212\ \(0\)\
\-\ history\\:\\ 0\\.005032897815382019\ \(0\)\
\-\ lesions\\:\\ 0\\.004877527732076647\ \(0\)\
\-\ due\\:\\ 0\\.0048619981939292956\ \(0\)\
\-\ than\\:\\ 0\\.004774091375092268\ \(0\)\
\-\ prior\\:\\ 0\\.004678278831987982\ \(0\)\
\-\ abdominal\\:\\ 0\\.00455419880196613\ \(0\)\
\-\ physical\\:\\ 0\\.004470160489512235\ \(0\)\
\-\ pain\\:\\ 0\\.004450354658979679\ \(0\)\
\-\ bilateral\\:\\ 0\\.004421786203229091\ \(0\)\
\-\ were\\:\\ 0\\.004137071080362305\ \(0\)\
\-\ well\\:\\ 0\\.0041217077888457375\ \(0\)\
\-\ exam\\:\\ 0\\.004002631002024601\ \(0\)\
\-\ case\\:\\ 0\\.003986150176689277\ \(0\)\
\-\ after\\:\\ 0\\.00376972537869766\ \(0\)\
\-\ treatment\\:\\ 0\\.003687882643072254\ \(0\)\
\-\ male\\:\\ 0\\.003294681317457299\ \(0\)\
\-\ that\\:\\ 0\\.0031470804446883226\ \(0\)\
\-\ disease\\:\\ 0\\.0029781184247669595\ \(0\)\
\-\ to\\:\\ 0\\.0027317789452643046\ \(0\)\
\-\ and\\:\\ 0\\.002686701578092813\ \(0\)\
\-\ left\\:\\ 0\\.0020386039856565346\ \(0\)\
\-\ patient\\:\\ 0\\.0018264220275402729\ \(0\)\
\-\ on\\:\\ 0\\.0015434776383058168\ \(0\)\
\-\ with\\:\\ 0\\.0009979034208092942\ \(0\)\
\-\ \\.\\:\\ 0\\.0009839956700756964\ \(0\)\
\-\ in\\:\\ 0\\.0008985015568022493\ \(0\)\
\-\ a\\:\\ 0\\.0008456285753061861\ \(0\)\
\-\ the\\:\\ 0\\.0005895491885016025\ \(0\)\
\-\ of\\:\\ 0\\.0004968179138506969\ \(0\)\
